bluebird bio (BLUE) PT Raised to $87 at Maxim Group

December 1, 2016 11:45 AM EST Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and lifted his price target on bluebird bio (NASDAQ: BLUE) to ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login